Dexmedetomidine

interleukin 1 alpha ; Mus musculus







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35412062 Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1/IL1RA axis. 2022 Jul 1
2 35538293 MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis. 2022 Jul 1
3 33179100 Dexmedetomidine attenuates sevoflurane‑induced neurocognitive impairment through α2‑adrenoceptors. 2021 Jan 1
4 33821300 Dexmedetomidine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting the PI3K/Akt/FoxO1 signaling pathway. 2021 Jun 1
5 34079457 Dexmedetomidine Mitigated NLRP3-Mediated Neuroinflammation via the Ubiquitin-Autophagy Pathway to Improve Perioperative Neurocognitive Disorder in Mice. 2021 4
6 34172807 Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke. 2021 Jun 25 1
7 34278508 Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway. 2021 Sep 2
8 34421084 Dexmedetomidine relieved neuropathic pain and inflammation response induced by CCI through HMGB1/TLR4/NF-κB signal pathway. 2021 Aug 20 1
9 31954762 Dexmedetomidine attenuates ethanol-induced inhibition of hippocampal neurogenesis in neonatal mice. 2020 Mar 1 1
10 30964190 Therapeutic effect of dexmedetomidine on intracerebral hemorrhage via regulating NLRP3. 2019 Mar 1
11 31185237 Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study. 2019 Oct 15 1
12 28173746 Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice. 2017 Apr 1